IFNA1 and COVID-19: The risk of life-threatening COVID-19 is even higher in patients with auto-Abs neutralizing both IFN-αs and IFN-ω, further suggesting that the IFN-α subtypes and IFN-ω may not be completely redundant in the context of COVID-19.